Since its establishment in 1994, Shenzhen Xingyin Pharmaceutical Co., LTD. (hereinafter referred to as "Xingyin Pharmaceutical") has focused on the development of the pharmaceutical industry and gradually grown into a comprehensive pharmaceutical enterprise integrating science, industry and trade. Over the past 20 years, Xingyin Pharmaceutical has set up 13 pharmaceutical subsidiaries in Shenzhen, Nanjing, Anhui, Hubei, Sichuan and other places, set up 5 regions, 8 provinces, 63 offices, 22 OTC sales areas in the country, and created a professional academic marketing team. So far, Xingyin Pharmaceutical has a complete pharmaceutical industry chain, is a strong independent innovation ability, high sustainable development strength of excellent pharmaceutical enterprises.

Since its establishment, Xingyin Medicine has always adhered to the values of "integrity, gratitude, cooperation and win-win", adhered to the dedication of quality products, served the people and benefited the society. In the early 1990s, Xingyin Medicine introduced Meizhling tablet, a pure botanical medicine originally produced in Germany. Over the years, Xingnaling tablet, Xingrui Ke, Gegen Decoction mixture, Xingruiling, compound Codeine phosphate oral solution and other products with excellent quality, significant efficacy and high safety have been widely used in clinical departments of major hospitals in China, and have won unanimous praise from clinical experts and patients.

In 2002, Xingyin Pharmaceutical built a large modern drug production base - Nanjing Xingyin Pharmaceutical Industrial Park, covering an area of 250 mu in Lishui Economic Development Zone, Jiangsu Province, engaged in the production of various dosage forms of drugs. In order to realize the continuous innovation of drug research and development and production technology, Xingyin Pharmaceutical has successively invested in Nanjing Xingyin Pharmaceutical Research Co., LTD., invested in Anhui Heyuan Pharmaceutical Technology Co., LTD., and built Shenzhen Jianyuan Pharmaceutical Technology Co., LTD. Xingyin Pharmaceutical also invested in the construction of a 5,000 square meter factory as a production line in Shenzhen National High-tech Development Zone, as well as 3,800 square meters of R & D base, 2,500 square meters of quality inspection conference center, specializing in biopharmaceutical research and development and production. At present, Xingyin Pharmaceutical has nearly 100 invention patents and product design patents, more than 30 kinds of new drugs in research, and no less than 4 new biological agents enter the approval sequence every year. As a national high-tech enterprise, Xingyin Pharmaceutical invests heavily in the field of pharmaceutical research and development every year, and strives to accelerate the development of innovative drugs and become stronger and bigger in the pharmaceutical market.

While developing and growing, Xingyin Medicine has always been grateful to the society, enthusiastically supporting public welfare and charity, actively donating money and medicine in various public welfare activities, and doing its best to help people in need. Xingyin Pharmaceutical has been awarded as "China Integrity Enterprise", "China Excellent Innovative Enterprise", "Guangdong Province\'s most core competitive enterprise", "Shenzhen High-tech Enterprise", "Guangdong Province\'s most socially responsible enterprise in the 30 years of reform and opening up". And was awarded the "Shenzhen famous brand", "Guangdong Province National Famous brand", "Guangdong Province integrity benchmarking enterprise", "Guangdong Province famous trademark" and other honorary titles.